[go: up one dir, main page]

AU2001247306A1 - Immune system-related polynucleotides, polypeptides, and antibodies - Google Patents

Immune system-related polynucleotides, polypeptides, and antibodies

Info

Publication number
AU2001247306A1
AU2001247306A1 AU2001247306A AU4730601A AU2001247306A1 AU 2001247306 A1 AU2001247306 A1 AU 2001247306A1 AU 2001247306 A AU2001247306 A AU 2001247306A AU 4730601 A AU4730601 A AU 4730601A AU 2001247306 A1 AU2001247306 A1 AU 2001247306A1
Authority
AU
Australia
Prior art keywords
polypeptides
antibodies
immune system
related polynucleotides
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247306A
Inventor
Gil H. Choi
Reinhard Ebner
Gregory A. Endress
Joachim R Gruber
David Hilbert
Joseph J. Kenny
Paul A Moore
Jian Ni
Steven M Ruben
Daniel R Soppet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2001247306A1 publication Critical patent/AU2001247306A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
AU2001247306A 2000-03-08 2001-03-07 Immune system-related polynucleotides, polypeptides, and antibodies Abandoned AU2001247306A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18787300P 2000-03-08 2000-03-08
US60187873 2000-03-08
US22436700P 2000-08-11 2000-08-11
US60224367 2000-08-11
PCT/US2001/007260 WO2001066722A1 (en) 2000-03-08 2001-03-07 Immune system-related polynucleotides, polypeptides, and antibodies

Publications (1)

Publication Number Publication Date
AU2001247306A1 true AU2001247306A1 (en) 2001-09-17

Family

ID=26883496

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247306A Abandoned AU2001247306A1 (en) 2000-03-08 2001-03-07 Immune system-related polynucleotides, polypeptides, and antibodies

Country Status (6)

Country Link
US (1) US20020164692A1 (en)
EP (1) EP1268773A1 (en)
JP (1) JP2004500101A (en)
AU (1) AU2001247306A1 (en)
CA (1) CA2399943A1 (en)
WO (1) WO2001066722A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001031004A1 (en) * 1999-10-27 2001-05-03 Takeda Chemical Industries, Ltd. Novel protein and use thereof
US20040039166A1 (en) * 2000-08-10 2004-02-26 Bernd Hentsch Iapl-3 a novel protein inhibitor of apoptosis protein
BRPI0511952A (en) 2004-06-10 2008-01-29 Zymogenetics Inc isolated soluble receptor, antibody or antibody fragment, and methods of reducing il-17a-induced or il-17f-induced inflammation, treating an affected mammal with an inflammatory disease, and a pathological condition in an individual associated with zcytor activity14
US20070249533A1 (en) 2005-09-28 2007-10-25 Levin Steven D Il-17a and il-17f antagonists and methods of using the same
US7790676B2 (en) 2007-03-28 2010-09-07 Zymogenetics, Inc. Soluble IL-17RA/RC fusion proteins
SG11202103250UA (en) * 2018-10-01 2021-04-29 Toru Miyazaki Therapeutic agent for neurodegenerative disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062943A2 (en) * 1998-06-02 1999-12-09 Millenium Pharmaceuticals, Inc. Novel molecules of the aip-related protein family and uses thereof

Also Published As

Publication number Publication date
EP1268773A1 (en) 2003-01-02
CA2399943A1 (en) 2001-09-13
WO2001066722A1 (en) 2001-09-13
JP2004500101A (en) 2004-01-08
US20020164692A1 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
AU2001271714A1 (en) B7-like polynucleotides, polypeptides, and antibodies
AU2001233156A1 (en) Bcl-2-like polynucleotides, polypeptides, and antibodies
AU2002320314A1 (en) Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2001271744A1 (en) Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9
AU3075801A (en) Transferrin polynucleotides, polypeptides, and antibodies
AU1191001A (en) Plasminogen-like polynucleotides, polypeptides, and antibodies
AU7337400A (en) B7-like polynucleotides, polypeptides, and antibodies
AU2002365924A1 (en) Herbal immune system stimulant
AU2001253323A1 (en) Extracellular matrix polynucleotides, polypeptides, and antibodies
IL158397A0 (en) Polypeptides, their preparation and their use
AU1582401A (en) Uteroglobin-like polynucleotides, polypeptides, and antibodies
AU2002316578A1 (en) Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
AU7335400A (en) Attractin-like polynucleotides, polypeptides, and antibodies
AU2001238585A1 (en) Human polynucleotides, polypeptides, and antibodies
AU2001247306A1 (en) Immune system-related polynucleotides, polypeptides, and antibodies
AU2001241611A1 (en) Adam polynucleotides, polypeptides, and antibodies
AU4001000A (en) Dwf4 polynucleotides, polypeptides and uses thereof
EP1263940A4 (en) Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
AU2002351469A1 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
AU2001229517A1 (en) Human polynucleotides, polypeptides, and antibodies
EP1212415A4 (en) Pgrp-l polynucleotides, polypeptides, and antibodies
IL161234A0 (en) Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
AU1933401A (en) Cytokine receptor-like polynucleotides, polypeptides, and antibodies
AU2002241570A1 (en) Human proteins, polynucleotides encoding them and methods of using the same